Vaxxilon AG

Reinach, CH· latest recorded location

Vaxxilon AG is named on 1 US grants and 2 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).

Granted patents: 1
Published applications: 2
Inventors: 14
Granted in 2026 so far: 0
Most recent grant: 25 May 2021

Filings by year

Vaxxilon AG: granted patents and published applications per publication year
Year	Granted patents	Published applications
2019	0	2
2020	0	0
2021	1	0

By publication year.

Technology areas

Share of 3 documents

A61PTherapeutic uses of medicines3
A61KMedicines and medical preparations2
C07HSugars2
G01NInvestigating or analysing materials by determining their chemical or physical properties1
Y02ATechnologies for adaptation to climate change1

Recent patents

Stable hydrolysis-resistant synthetic polyribosylribitolphosphate derivatives as vaccines against Haemophilus influenzae type b25 May 2021US 11,014,952 B2

All 1 patents

Most cited

By later US patents

None of its patents has been cited by a later US patent yet.